|
||||||||||
 |
||||||||||
|
||||||||||
The Stingy News Weekly (04/30/2018)
New from StingyInvestor The Top 1000 "Below are the 1,000 largest publicly traded Canadian corporations, as measured by assets. You can rank them by revenue, profit, assets or market cap using the drop down menu below. Tap a company name for more data, including a live stock price look-up." [$] Meet the Top 1000 Megastars "Not sure which Top 1000 companies to buy? We analyzed the data for you to arrive at a shortlist of 20 stocks. Last year's picks delivered a stunning 16.2% return" [$] Stingy Links Lessons from John Cleese "It's absolutely no good just writing a straight script and then sticking half a dozen jokes in, because people would just remember the jokes and forget the teaching points" [Behaviour] Atul Gawande interview "Sure, medical progress has been astounding. But today the U.S. spends more on healthcare than any other country, with so-so outcomes. Atul Gawande - cancer surgeon, public-health researcher, and best-selling author - has some simple ideas for treating a painfully complex system." [Health] Factor investing: art and science "Having studied finance for a long time, I think I now know less about how the stock market works. In fact, I probably should have stopped studying finance after I read Ben Graham's Intelligent Investor, over 20 years ago. Life would be a lot easier, or at least less complicated. Adhering to Graham's straightforward value investing ethos certainly worked out for Warren Buffett" [Value Investing] The Rothery Report (Learn More | Subscribe) The Rothery Report provides research on select deep-value stocks in North America. Discover overlooked and undervalued stocks in quarterly investment reports which provide detailed analysis of Canadian and U.S. stocks. Weekly email news and additional updates keep subscribers informed about new opportunities and developments.
|
| |||||||||
| ||||||||||
| ||||||||||
| Disclaimers: Consult with a qualified investment adviser before trading. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, financial advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. More... | ||||||||||
